AI ScreeningAI ChatPricing
  1. US-listed companies
  2. Blueprint Medicines Corp
  3. Financials
  4. Net income margin (%)

Blueprint Medicines Corp【BPMC】

Market cap
$8.4B
P/E ratio
SummaryFinancials
Period EndNet income margin (%) YoY (%)
Dec 31, 2024-13.2-93.51%
Dec 31, 2023-203.3-25.60%
Dec 31, 2022-273.2-23.60%
Dec 31, 2021-357.7-1004.45%
Dec 31, 202039.5-107.56%
Dec 31, 2019-522.8-1.65%
Dec 31, 2018-531.5-23.11%
Dec 31, 2017-691.3+164.83%
Dec 31, 2016-261-43.61%
Dec 31, 2015-462.9

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)